Streetbeat News

Regulatory

MRK

Health Canada has approved Merck's KEYTRUDA in combination with chemotherapy as a first-line treatment for adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma. This approval marks a significant advancement in the treatment options available for patients with this type of cancer.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 11:07 am

TSLA

Tesla Inc (NASDAQ:TSLA) is recalling 3,878 Cybertruck vehicles due to a risk of unintended acceleration caused by the accelerator pedal pad potentially dislodging. The company will repair or replace the accelerator pedal assembly at no cost. Tesla has not reported any related collisions or injuries and is taking precautionary measures to equip new Cybertrucks with updated pedals and fix those in delivery.

Portfolio Pulse from Anan Ashraf

April 19, 2024 | 10:55 am

SOL

Emeren Group has received a notice of non-compliance from the NYSE due to the late filing of required documents. This notice is a procedural step by the NYSE in cases where listed companies fail to meet the exchange's filing deadlines. Emeren Group, which is likely represented by the ticker symbol SOL, must now address this issue to regain compliance and avoid potential negative consequences such as delisting.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 10:03 am

BA

Boeing Co. (NYSE:BA) faces 32 whistleblower complaints over three years, with allegations including employer retaliation, fraud, and safety concerns. The Occupational Safety and Health Administration (OSHA) is investigating, with five cases still pending. Complaints cover aviation safety, workplace safety, fraud, and toxic chemicals control. Boeing emphasizes its commitment to safety and non-retaliation, highlighting its Go4Zero safety initiative's success in reducing workplace injuries.

Portfolio Pulse from Benzinga Neuro

April 19, 2024 | 10:01 am

EIS

SPY

USO

The Biden administration is considering allocating over $1 billion in new arms for Israel, in addition to a military aid bill currently before the House. This move comes amid ongoing conflict in Gaza.

Portfolio Pulse from Charles Gross

April 19, 2024 | 9:35 am

TSLA

Tesla is conducting a recall of certain 2024 Cybertruck vehicles, according to a report by Reuters citing the National Highway Traffic Safety Administration (NHTSA).

Portfolio Pulse from Charles Gross

April 19, 2024 | 9:26 am

BA

Boeing Co. (NYSE:BA) is planning to enter Asia's urban air mobility market by 2030 with flying cars, developing eVTOL vehicles at Wisk Aero in California. The company aims to obtain U.S. certification before expanding into Asia, with a new R&D base opened in Nagoya, Japan. This move comes as Boeing faces challenges in its core aircraft manufacturing business, including safety concerns and a significant drop in commercial aircraft deliveries, leading to a 32% decline in its stock price year-to-date.

Portfolio Pulse from Anan Ashraf

April 19, 2024 | 9:26 am

AAPL

NVDA

TSM

Sherman Lin, CEO of the Taiwan Stock Exchange, highlighted Taiwan's significant role in the global AI and semiconductor industries, attributing the strong performance of the Taiwan Weighted Index to high demand for chips and a robust server supply chain. Taiwan Semiconductor (TSMC), as the world's largest contract chipmaker and a key supplier to companies like Apple and NVIDIA, underscores Taiwan's dominance. Despite challenges like the U.S. elections and military conflicts, Taiwan's resilience and strategic 'chip diplomacy' keep it at the forefront of the semiconductor industry.

Portfolio Pulse from Benzinga Neuro

April 19, 2024 | 8:39 am

BRSH

Brüush Oral Care has received an additional delisting threat from Nasdaq due to non-compliance with Audit Committee Requirements following a board member's resignation. A hearing is scheduled for April 25, 2024, to address this and other deficiencies.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 6:51 am

NGMS

NeoGames and Aristocrat have received the final regulatory approvals needed for their acquisition deal, clearing the last hurdle for the transaction to proceed.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 6:39 am